Information Technology
THE DIGITALISATION OF THE CRYSTALLISATION PROCESS
A holistic control strategy in Pharma 4.0
One of the main issues faced by the pharmaceutical industry is ensuring reliable and timely access to secure innovative and economical medication These issues are becoming more critical due to the worlds growing but ageing population
The Cyber-Physical Security of Pharmaceutical Manufacturing Processes
The cyberphysical security is no longer an area that should be overlooked Unfortunately cyberphysical attacks of all kinds may cost companies a great amount of money and countless lives
PHARMA SUPPLY CHAIN INTELLIGENCE
IT FOCUS
New technologies advanced software systems and the integration of IT within the pharma supply chain are increasingly playing a pivotal part in protecting pharmaceutical payloads worldwide
DIGITAL TECHNOLOGY IN PHARMA
Ripe for disruption
While the life sciences sector has incrementally adopted digital technologies over the years the rate of digital transformation over the next five years looks to be unprecedented
CUSTOMER CENTRICITY ON SOCIAL MEDIA
ARE THERE LESSONS FOR PHARMA FROM OTHER INDUSTRIES?
Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didnt align with the hotel on the specification Customers in such scenarios find themselves at a loss for venting out their frustration and social media seems a good refuge
IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS
OPENING NEW POSSIBILITIES FOR DRUG DEVELOPMENT
was the year where pharma realised that Big Data could dramatically increase the value of data produced during drug development or coming from Electronic Medical Records EMRs and medical devices
Creating Better Clean Label Soft Gels Without Gelatin Crosslinking
Soft gels also known as soft capsules or soft caps are a highly popular pharmaceutical and nutraceutical dosage form with around units consumed every second globally A forecast by HJR Research predicts a CAGR of per cent over the next decade with the global market value expected to reach billion by During the same period the AsiaPacific region...
R&D DATA HUB
Breaking Silos to Enable Analytics
Traditionally controlled trials have dominated drug development Increasing focus on rare diseases and access to relevant patients have led to challenges where no single dataset can fulfil all research and development requirements Biopharmaceutical companies need to prioritise their business questions and map them to the appropriate source Construct...
Take a Pass on the 3pm Samples
Gone are the days when chemists would wait patiently for paper reports on their particular sample results to be sent to them The introduction of informatics technology brought with it results that can be delivered by email and uploaded through a central system or stored in the cloud so that they could be presented quickly and allow for timely decis...
Cost effective Data Operations
The need for an E2E data standards ecosystem
The main focus of Data Operations groups within biopharmaceutical companies is to ensure the highest possible quality of data for clinical studies With the combined challenges of compliance to Data Standards increasing diversity of data collection tools nearreal time visualisation of safety data and the opportunity of insilico studies Data Operatio...
